Carson Allaria Wealth Management, Ltd. Moderna, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q3 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 112 shares of MRNA stock, worth $4,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112
Previous 173
35.26%
Holding current value
$4,410
Previous $20,000
65.0%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.67 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.58 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$663 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...